Position paper on evidence-based regulation of bisphenols

Why regulatory decisions should weigh the full body of scientific evidence.

Key points

  1. Decisions should rest on the full body of published evidence and on the assessments of competent authorities.
  2. Measures should be proportionate to the identified risk for each use.
  3. Essential applications need realistic transition timelines.